Inhibition of murine AIDS by a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine

Journal of Antimicrobial Chemotherapy

Volumn 50, Issue 5, 2002, Pages 639-647

  Rossi, Luigia ^a   Serafini, Sonja ^a   Franchetti, Palmarisa ^b   Casabianca, Anna ^a   Orlandi, Chiara ^a   Schiavano, Giuditta Fiorella ^a   Carnevali, Andrea ^c   Magnani, Mauro ^a  

^a UNIVERSITY OF URBINO   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

^c SAN SALVATORE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; DIDANOSINE; NELFINAVIR; NUCLEOTIDE DERIVATIVE; PRODRUG; TENOFOVIR; TENOFOVIR DISOPROXIL; VIRUS DNA; ZIDOVUDINE; ADENINE; DRUG DERIVATIVE; ORGANOPHOSPHORUS COMPOUND; PHOSPHONIC ACID DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DISEASE COURSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENCY; DRUG POTENTIATION; HYPERGAMMAGLOBULINEMIA; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE; LYMPHADENOPATHY; MONOTHERAPY; MOUSE; MOUSE STRAIN; NONHUMAN; PROVIRUS; RETROVIRUS; SPLENOMEGALY; ANIMAL; AREA UNDER THE CURVE; BLOOD; CHEMISTRY; COMPARATIVE STUDY; DRUG COMBINATION; INSTITUTE FOR CANCER RESEARCH MOUSE; RODENT DISEASE; SYNTHESIS;

ADENINE; ANIMALS; AREA UNDER CURVE; CHEMISTRY, PHARMACEUTICAL; DRUG COMBINATIONS; MICE; MICE, INBRED ICR; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; PRODRUGS; ZIDOVUDINE;

EID: 0036848259     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkf205     Document Type: Article

References (17)

1. Robbins, B. L. & Fridland, A. (1996). Metabolism and therapeutic activity of acyclic adenine phosphonate analogs. International Antiviral News 4, 57-8.
2. Mulato, A. S. & Cherrington, J. M. (1997). Anti-HIV activity of adefovir (PMEA) and PMPA in combination with antiretroviral compounds: in vitro analyses. Antiviral Research 36, 91-7.
3. Hartley, J. W., Frederickson, T. N., Yetter, R. A., Makino, M. & Morse, H. C., III (1989). Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains. Journal of Virology 63, 1223-31.
4. Morse, H. C., III, Chattopadhyay, S. K., Makino, M., Frederickson, T. N., Hügin, A. W. & Hartley, J. W. (1992). Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS 6, 607-21.
5. Deeks, S. G., Barditch-Crovo, P., Lietman, P. S., Hwang, F., Cundy, K. C., Rooney, J. et al. (1998). Safety, pharmacokinetics, and antiretroviral activity of intravenous 9-[2-(R)-(phosphonomethoxy)propyl)adenine, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults. Antimicrobial Agents and Chemotherapy 42, 2380-4.
6. Franchetti, P., Rossi, L., Cappellacci, L., Pasqualini, M., Grifantini, M., Balestra, E. et al. (2001). Inhibition of HIV-1 replication in macrophages by red blood cell-mediated delivery of a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine (PMPA). Antiviral Chemistry and Chemotherapy 12, 151-9.
7. Magnani, M., Rossi, L., Cucchiarini, L. & Stocchi, V. (1989). Reversed-phase liquid chromatographic determination of 2′,3′-dideoxycytidine in human blood samples. Journal of Chromatography 491, 215-20.
8. Mosier, D. E., Yetter, R. A. & Morse, H. C., III (1987). Functional T lymphocytes are required for a murine retrovirus induced immunodeficiency (MAIDS). Journal of Experimental Medicine 165, 1737-42.
9. National Institutes of Health. (1986). Guide for the Care and Use of Laboratory Animals. NIH Publication 86-23. National Institutes of Health, Bethesda, MD, USA.
10. Fraternale, A., Casabianca, A., Rossi, L., Chiarantini, L., Brandi, G., Aluigi, G. et al. (1996). Inhibition of murine AIDS by combination of AZT and dideoxycytidine-5′-triphosphate. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology 12, 164-73.
11. Casabianca, A., Vallanti, G. & Magnani, M. (1998). Competitive PCR for quantification of BM5d proviral DNA in mice with AIDS. Journal of Clinical Microbiology 36, 2371-4.
12. Jolicoeur, P. (1991). Murine acquired immunodeficiency syndrome (MAIDS): an animal model to study the AIDS pathogenesis. FASEB Journal 5, 2398-405.
13. Clague, M. J. & Cherry, R. J. (1989). A comparative study of band 3 aggregation in erythrocyte membrane by melittin and other cationic agents. Biochimica et Biophysica Acta 980, 93-9.
14. Perno, C. F., Yarchoan, R., Balzarini, J., Bergamini, A., Milanese, G., Pauwels, R. et al. (1992). Different pattern of activity of inhibitors of the immunodeficiency virus in lymphocytes and monocyte/macrophages. Antiviral Research 17, 289-304.
15. Shaw, J. P., Sucoka, C. M., Oliyai, R., Lee, W. A., Arimilli, M. N., Kim, C. U. et al. (1997). Metabolism and pharmacokinetics of novel oral prodrugs of 9-[(R)-2-phosphonomethoxypropyl]adenine (PMPA) in dogs. Pharmacological Research 14, 1824-9.
16. Trang, J. M., Prejean, J. D., James, R. H., Irwin, R. D., Goehl, T. H. & Page, J. G. (1993). Zidovudine bioavailability and linear pharmacokinetics in female B6C3F1 mice. Drug Metabolism and Disposition 21, 189-93.
17. Suruga, Y., Makino, M., Okada, Y., Tanaka, H., De Clercq, E. & Baba, M. (1998). Prevention of murine AIDS development by (R)-9-(2-phosphonylmethoxypropyl)adenine. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology 18, 316-22.